The upregulation of CDCA8 has been reported in diverse types of cancer, including colorectal, breast, gastric, and lung cancer, implying that inhibition of CDCA8 expression could be an effective therapeutic strategy [14,25,26]. Here, CDCA8 is linked to lung carcinoma.